Interestingly, MAL overexpression was reported in ~20% of investigated lymphoma, and a whole exome sequencing in human recently revealed that MAL SNP R81C activated its downstream signaling to enhance NF-κB gene expression, whose constitutive activity is characteristic of B cell lymphoma (50, 63). The gene discussed is MAL; the disease is B-cell non-Hodgkin lymphoma.